# Ernexa Therapeutics Inc.: Form 8-K, filed Jul 2, 2026

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2026-07-02
- Accepted by EDGAR: Jul 2, 2026, 20:30 ET
- Period: 2026-07-01
- Accession: 0001493152-26-031920
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315226031920/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315226031920/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315226031920/form8-k.htm

Filed Jul 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-031920. Last ingested by Listed: Oct 24, 2026, 14:54 ET. No prices; not investment advice.